Post by
Dude51 on Apr 11, 2021 10:53pm
Quote form Andrew Salzman, check out interview
Claritas Investors website
"Claritas really has, in my judgment, a fantastic platform technology. It's novel, and it's a leader in the field of nitric oxide. All the data to date have shown efficacy in models of sepsis and pneumonia, and also, as a nitric oxide donor, there will be efficacy against the COVID virus. So, Claritas is beautifully positioned right now to exploit this technology to its fullest extent."
GLTA